Emerging Bispecifics Myeloma Patients Should Know About | Dr. Joshua Richter | The Patient Story The Patient Story 21:02 2 years ago 760 Далее Скачать
What Are Bispecifics in Multiple Myeloma? (For Patients and Caregivers) | Dr. Joshua Richter The Patient Story 5:20 2 years ago 424 Далее Скачать
What are CELMoDs in Multiple Myeloma (& When Will They Be Available?) | Dr. Joshua Richter The Patient Story 3:04 2 years ago 328 Далее Скачать
What to Expect with CAR T Cell Therapy and Bispecifics in Myeloma (2022) | Dr. Joshua Richter The Patient Story 6:18 2 years ago 764 Далее Скачать
Questions to Ask My Doctor about New Myeloma Treatments | Dr. Joshua Richter | The Patient Story The Patient Story 5:02 2 years ago 575 Далее Скачать
Bispecific Antibodies | Joshua Richter, MD | ASH 2022 HealthTree Foundation for Multiple Myeloma 3:11 2 years ago 875 Далее Скачать
What are Bispecific Antibodies? How they are Revolutionizing Multiple Myeloma Treatment! The Patient Story 12:01 1 year ago 2 213 Далее Скачать
Cevostamab, a FcRH5 bispecific antibody, for RRMM | Joshua Richter, MD | #ASH2024 HealthTree Foundation for Multiple Myeloma 3:24 2 weeks ago 179 Далее Скачать
Cevostamab in RRMM Patients: CAMMA 2 Study Results | Joshua Richter, MD | EHA 2024 HealthTree Foundation for Multiple Myeloma 2:25 6 months ago 261 Далее Скачать
Latest Cancer Treatments: Hear from Top Multiple Myeloma Specialists | The Patient Story The Patient Story 1:10:26 3 years ago 2 241 Далее Скачать
Outcomes of patients with myeloma receiving fixed-duration cevostamab VJHemOnc – Video Journal of Hematology & HemOnc 1:02 2 years ago 119 Далее Скачать
Multiple Myeloma in 2023: What Patients & Caregivers Need to Know Now! | The Patient Story The Patient Story 31:15 2 years ago 37 526 Далее Скачать
Safety & efficacy of cevostamab in patients with heavily pre-treated R/R multiple myeloma VJHemOnc – Video Journal of Hematology & HemOnc 2:06 1 year ago 234 Далее Скачать
Myeloma Research | CAR-T Cell & Bispecifics Study Updates Patient Empowerment Network 8:56 2 years ago 174 Далее Скачать
T Cell Re-direction Therapy | Joshua Richter, MD | EHA 2022 HealthTree Foundation for Multiple Myeloma 2:18 2 years ago 216 Далее Скачать
Safety and efficacy of linvoseltamab for patients with R/R multiple myeloma VJHemOnc – Video Journal of Hematology & HemOnc 1:25 2 years ago 253 Далее Скачать
How Often Should MRD Testing Occur During Remission (and an MRD Overview) with Dr. Joshua Richter HealthTree Foundation for Multiple Myeloma 57:58 2 years ago 1 055 Далее Скачать
Updates from the LINKER-MM1 study: linvoseltamab in R/R multiple myeloma VJHemOnc – Video Journal of Hematology & HemOnc 1:33 1 year ago 129 Далее Скачать
Thriving with Myeloma: What You Should Know About Care and Treatment Patient Empowerment Network 31:04 2 years ago 13 171 Далее Скачать
What should myeloma patients know about bispecific antibodies? International Myeloma Foundation 3:25 2 years ago 2 218 Далее Скачать
